Amylyx Pharmaceuticals logo

Senior Director, CMC Technical Development

Amylyx Pharmaceuticals

Cambridge, MAHybridPosted 1 day ago$247,000 - $278,000/year
Full TimeDirector & AboveManufacturing & CMCPharmaceutical
Original posting ↗

Summary

Amylyx is seeking a highly experienced Senior Director, CMC Technical Development to provide strategic and technical leadership across Amylyx's clinical and late-stage pipeline, including the Phase III synthetic peptide avexitide, Phase I antisense oligonucleotide AMX0114, and Phase 2 small molecule AMX0035. This leader will be responsible for driving phase-appropriate technical development including drug substance and drug product process development, product characterization, formulation selection, process scale-up, and validation readiness in partnership with internal CMC functions and external CDMOs. This role reports to the Senior Vice President, CMC and External Manufacturing.

Job description

The Opportunity

Amylyx is seeking a highly experienced Senior Director, CMC Technical Development to provide strategic and technical leadership across Amylyx's clinical and late-stage pipeline, including the Phase III synthetic peptide avexitide, Phase I antisense oligonucleotide AMX0114, and Phase 2 small molecule AMX0035. This leader will be responsible for driving phase-appropriate technical development including drug substance and drug product process development, product characterization, formulation selection, process scale-up, and validation readiness in partnership with internal CMC functions and external CDMOs. This role reports to the Senior Vice President, CMC and External Manufacturing.

Responsibilities

Strategic Technical Leadership

  • Lead technical development across Amylyx's pipeline, ensuring plans are scientifically rigorous, phase-appropriate, and aligned with clinical, regulatory, quality, supply, and business objectives.
  • Serve directly or through direct reports as the Technical Development lead on CMC asset teams, accountable to provide clear technical requirements, risks, timelines, decision options, regulatory filing materials, and clinical supplies.
  • Provide input into target product profiles ensuring technical feasibility and translating into critical quality attributes and critical process parameters.
  • Partner with CMC Team Strategy lead(s) to integrate technical development plans into overall asset strategies.
  • Proactively identify critical path activities, technical risks, resource needs, and budget implications; develop practical mitigation plans and contingency strategies in collaboration with internal and external teams.
  • Provide technical leadership for CDMO evaluation, selection, onboarding, due diligence, technology transfer, and external development or manufacturing campaigns.
  • Travel to global manufacturing and development sites as needed to support technical transfers, GMP campaigns, and troubleshooting.

Process Development & Scale-Up

  • Lead phase-appropriate drug substance and drug product development for clinical and late-stage programs, including formulation and process optimization, scale-up, and process characterization.
  • Establish robust, scalable, reproducible, and cost-effective drug substance and drug product manufacturing processes capable of supporting clinical supply, regulatory submissions, and future commercial manufacture.
  • Develop and maintain control strategies and ensure manufacturing processes, specifications, and technical packages are scientifically justified and aligned with global regulatory expectations.
  • Serve as a technical subject matter expert through product registration, supporting technical assessments, development reports, process descriptions, control strategy documentation, and regulatory submission content.
  • Lead technical troubleshooting, deviation investigations, root-cause analyses, CAPAs, change controls, batch record review, campaign data review in collaboration with Quality and external partners to support clinical supply.
  • Review and approve key clinical CDMO technical documents, including protocols, batch records, campaign plans, development reports, deviation assessments, technical memos, and drug substance/drug product manufacturing documentation.

Regulatory and Commercial Readiness

  • Partner with Regulatory CMC to author, review, and defend technical content for INDs, NDAs, BLAs, MAAs, health authority questions, and briefing materials.
  • Support MSAT team with PPQ planning and commercial technical readiness by ensuring drug substance and drug product process understanding, control strategy, comparability, and manufacturing documentation are appropriately developed for late-stage programs approaching filing and launch.

People Management

  • Lead, mentor, and develop internal technical development team members and matrixed project leads, fostering scientific rigor, accountability, collaboration, urgency, and pragmatic decision-making.
  • Provide career development guidance, coaching, performance feedback, and succession planning for team members.
  • Allocate resources effectively across programs and ensure technical development priorities are aligned with organizational objectives, program milestones, and available capacity.
  • Build scalable technical development processes, templates, governance routines, and best practices appropriate for a growing biotech organization operating through external partners.
  • Promote technical excellence through coaching, training, knowledge sharing, and transparent communication across internal teams and CDMO partners.

Requirements

  • Advanced degree in chemistry, chemical engineering, pharmaceutical sciences, biochemistry, or a related scientific or engineering discipline; Ph.D. preferred.
  • Strong understanding of small molecule, synthetic peptide, oligonucleotide, RNA, and/or amino acid chemistries and related manufacturing technologies.
  • Minimum of 15 years of progressive pharmaceutical or biotechnology experience in technical development, process development, and late-stage CMC development including at least 5-8 years in a leadership capacity.
  • Demonstrated expertise developing phase-appropriate processes across modalities from early clinical development through late-stage filing and commercialization.
  • Deep expertise in Quality by Design (QbD), Advanced knowledge of cGMP expectations and relevant FDA, EMA, ICH, and other global CMC guidance and regulatory requirements.
  • Strong track record supporting global CMC submissions, health authority interactions, inspection readiness, and successful product approvals preferred.
  • Proven ability to operate independently, influence without direct authority, make sound technical decisions under ambiguity, and build trusted relationships with internal stakeholders and external partners.
  • Excellent leadership, communication, collaboration, technical writing, and executive-level presentation skills.
  • Ability to travel domestically and internationally up to 10%, with additional travel as business needs require.

Work Location and Conditions

Amylyx supports remote work opportunities within the United States. However, candidates must be able to attend meetings at the office in Cambridge, MA on a regular basis. Preference will be given to candidates who reside in the New England region and can be in person on an as needed basis.

Requirements

  • Advanced degree in chemistry, chemical engineering, pharmaceutical sciences, biochemistry, or a related scientific or engineering discipline; Ph.D. preferred
  • Strong understanding of small molecule, synthetic peptide, oligonucleotide, RNA, and/or amino acid chemistries and related manufacturing technologies
  • Minimum of 15 years of progressive pharmaceutical or biotechnology experience in technical development, process development, and late-stage CMC development
  • At least 5-8 years in a leadership capacity
  • Demonstrated expertise developing phase-appropriate processes across modalities from early clinical development through late-stage filing and commercialization
  • Deep expertise in Quality by Design (QbD)
  • Advanced knowledge of cGMP expectations and relevant FDA, EMA, ICH, and other global CMC guidance and regulatory requirements
  • Strong track record supporting global CMC submissions, health authority interactions, inspection readiness, and successful product approvals preferred
  • Proven ability to operate independently, influence without direct authority, make sound technical decisions under ambiguity, and build trusted relationships with internal stakeholders and external partners
  • Excellent leadership, communication, collaboration, technical writing, and executive-level presentation skills
  • Ability to travel domestically and internationally up to 10%

Benefits

  • Performance-based bonuses
  • Equity awards
  • Comprehensive benefits package

Company overview

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, founded in 2013 by co-CEOs Josh Cohen and Justin Klee. The company specializes in developing novel therapies for neurodegenerative diseases with high unmet medical needs, with a particular focus on amyotrophic lateral sclerosis (ALS), Wolfram syndrome, and post-bariatric hypoglycemia. Amylyx's lead investigational therapy, AMX0035, received FDA approval for ALS treatment under the brand name RELYVRIO in September 2022. The company employs a rigorous scientific approach to target multiple pathological pathways in neurodegeneration, with additional pipeline candidates including avexitide for metabolic disorders and AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS. With a team of 201-500 employees, Amylyx combines therapeutic development expertise with commercialization capabilities to address some of medicine's most challenging conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.